Navigation Links
MD Anderson announces immunotherapy collaboration with GSK
Date:4/8/2014

HOUSTON The University of Texas MD Anderson Cancer Center announced today it formed a research alliance with GlaxoSmithKline (GSK), a global leader in pharmaceutical development, to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer.

The collaboration completes an ambitious plan to partner with leading pharmaceutical companies to more rapidly develop cancer immunotherapies as part of MD Anderson's Moon Shots Program. Through this venture, GSK and MD Anderson will work together to identify new therapeutic approaches, evaluate patient responses in clinical trials and use those insights to develop immunotherapy drugs.

"With this agreement, we've now completed our fourth and final major collaboration with large companies who share our commitment to deliver on the promise of immunotherapy, using the resources of our immunotherapy platform," said Ferran Prat, Ph.D., J.D., and vice president of MD Anderson Strategic Industry Ventures. "We're also committed to help leading start-ups establish a foothold in this exciting field, but collaborating with this select group of highly committed companies will help bring new therapies to patients faster."

"This collaboration brings together MD Anderson's basic science capabilities with GSK's drug discovery and development expertise, and our growing immuno-oncology portfolio," said Axel Hoos, M.D., Ph.D., VP Oncology R&D, who leads GSK's immuno-oncology programs and has previous experience working with MD Anderson in this field. "The alliance will build on the strengths of both organizations to innovate in translational research, which will enhance drug development programs in this fast-growing area." Hoos developed the first immune checkpoint modulatory antibody (anti-CTLA-4) in a previous partnership with MD Anderson's Jim Allison, Ph.D.

MD Anderson recognized the potential of immune-based therapies by creating one of the platforms that su
'/>"/>

Contact: William Fitzgerald
wbfitzgerald@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MD Anderson honors 2 champions for women in medicine and research
2. MD Anderson, MedImmune join forces to advance cancer immunotherapy
3. MD Anderson researcher uncovers some of the ancient mysteries of leprosy
4. Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
5. MD Anderson guides intelligent redesign of cancer care delivery model
6. MD Anderson researcher Jim Allison wins Breakthrough Prize for his innovative cancer immunology rese
7. 4 from UT MD Anderson named Fellows in AAAS
8. Super Bowl Champion OJ Anderson Treated By Pro Player Health Alliance For Sleep Apnea With A Dental Device
9. Sleep Apnea Treatment Becoming More Popular in New York After Long Island Dental Sleep Medicine Begins Treatment on OJ Anderson, Giants Super Bowl Champion
10. Colleen’s Dream Foundation Gifts $10,000 to The University of Texas MD Anderson Cancer Center to Support Ovarian Cancer Research
11. MD Anderson educators win AEIRS/Elsevier Innovator of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 03, 2015 Dan E. Chambers, an ... special focus on capital crimes, recently spoke on the radio ... trial. The hosts of the Independent Journal Review radio show ... working first as a prosecutor and now as a criminal ... decisions made in the trial and sentencing of this high-profile ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 ... Alopecia. Alopecia is the loss of hair. Alopecia areata ... alopecia. Causes for alopecia include aging, genetics, illness, chemotherapy, ... male pattern hair loss, female diffuse hair loss, hairs ... as focal or diffuse and by the presence or ...
(Date:3/3/2015)... 2015 The first week of March ... Foundation. The event brings recognition to a rarely discussed ... According to the Centers for Disease Control , ... form or another. Too little or unrestful sleep is ... illness and depression, and even a higher likelihood of ...
(Date:3/3/2015)... The combinatorial, multi-gene GeneSight test has ... for patients with depression, and their use of ... genes that comprise the test, according to a ... and Assurex Health, and published online by The ... of the GeneSight Psychotropic test is based on ...
(Date:3/3/2015)... 03, 2015 The North ... to grow from $1,224.6 million to $1,694.6 ... 2014 and 2019. , Browse through the ... market for an analysis of industry trends ... tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , ...
Breaking Medicine News(10 mins):Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3
... in the UK has found a way to make carbon ... a new form of drug delivery// . ... chemically modified carbon nanotubes by adding a range of different ... a variety of cell types, including human cancer cells. ...
... an independent risk factor for HIV infection, according to ... Sexually Transmitted Infections. The researchers conducted// a meta-analysis of ... looking at the link between smoking and progression to ... ,There is a growing recognition that smoking can increase ...
... to treat diabetes and thought to hold great promise ... (PCOS), is less useful for helping women with the ... the infertility drug clomiphene, report researchers in an NIH ... most comprehensive effort yet to compare the two drugs ...
... Research Centre Friday became the first in the country to ... quality patient care. ,The National Accreditation Board for ... of our focus on quality", Suyash Borar, the hospital's chief ... be a tool to win over patients from the US, ...
... of the biggest controversies in fetal surgery and the ... physicians// around the world: What's the best way to ... common conditions requiring fetal surgery and the leading cause ... study on TTTS, conducted at 17 centers in the ...
... assistant professor in Indiana University Bloomington's Department of Applied ... of teenagers have a conversation on sex with their ... phase in the process of growing up. Love and ... The researcher suggests that an open talk on sex ...
Cached Medicine News:Health News:Carbon Nanoneedles For Drug Delivery 2Health News:Carbon Nanoneedles For Drug Delivery 3Health News:Carbon Nanoneedles For Drug Delivery 4Health News:Smoking Increases Risk of HIV Acquisition 2Health News:Standard Therapy More Effective in Common Fertility Disorder 2Health News:Standard Therapy More Effective in Common Fertility Disorder 3Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x5lz9r/global_poc ) ... Diagnostics Market 2015-2019" report to their offering. ... Diagnostics market to grow at a CAGR of 8.47 ... diagnostics are IVD devices and tools used for diagnosing ... use of these devices helps in the rapid diagnosis ...
(Date:3/3/2015)... , March 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... or "the Company"), a specialty pharmaceutical company focused on ... present at the 27th Annual ROTH Conference, which will ... Niguel in Dana Point, California . ... at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... of the "Global Ultrasound Equipment Market 2015-2019" ... The Global Ultrasound Equipment market to ... period 2014-2019 Ultrasound equipment are used ... systems are extensively used by cardiologists, radiologists, surgeons, ...
Breaking Medicine Technology:Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... Md., April 15 MedImmune today announced,that it ... potential treatment,for patients with asthma, with the start ... targeting interleukin-13 (IL-13). One of the,studies is a ... designed to,assess the potential of the anti-IL-13 MAb ...
... Effort utilizes Phreesia,s automated patient check-in system to enable ... better management of ... Inc., the Patient Check-In,Company, has announced that it will ... University Medical Center into its,electronic patient intake process, thereby ...
Cached Medicine Technology:MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 2MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13 3Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: